Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Is a |
betamethasonacetatpræparat |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Is a |
betamethasondinatriumphosphatpræparat |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Betamethasone acetate |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Betamethasone sodium phosphate |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
glucocorticoidhormon |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Is a |
Betamethasone-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Has manufactured dose form |
Suspension for injection |
false |
Inferred relationship |
Some |
|
|
betamethasonacetat 3 mg/ml + betamethasondinatriumphosphat 3 mg/ml injektionsvæske, suspension |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|